An overview to pharmaceutical financing in Iran M Varmaghani, A Hashemi-Meshkini, A Abdollahiasl, E Heidari, HS Zekri, ... Journal of Pharmacoeconomics and Pharmaceutical Management 2 (1/2), 45-49, 2016 | 12 | 2016 |
Tramadol versus diclofenac in pain management after cesarean section: A cost analysis study S Merrikhihaghi, A Farshchi, B Farshchi, S Farshchi, F Abedin-Dorkoosh Journal of Pharmacoeconomics and Pharmaceutical Management 1 (1/2), 22-24, 2015 | 12 | 2015 |
Economic burden of irrational use of injectable form of Dexamethasone: a warning to health system F Soleymani, M Haerizadeh, A Farshchi Journal of Pharmacoeconomics and Pharmaceutical Management 1 (3/4), 56-58, 2015 | 11 | 2015 |
Factors affecting technology commercialization in Iranian knowledge based pharmaceutical companies R Radmanesh, A Kebriaeezadeh Journal of Pharmacoeconomics and Pharmaceutical Management 1 (3/4), 65-68, 2015 | 6 | 2015 |
Study of self-medication status among referring patients to Kashan pharmacies H Hayati, B Khosravi, A Kebriaeezadeh, M Khanizade Journal of Pharmacoeconomics and Pharmaceutical Management 1 (3/4), 45-48, 2015 | 6 | 2015 |
A new approach in identifying and evaluating quality risks in the pharmaceutical industry M Hajimolaali, A Kebriaeezadeh, A Abdollahiasl, H Safari, A Yektadoost Journal of Pharmacoeconomics and Pharmaceutical Management 3 (1/2), 17-20, 2017 | 5 | 2017 |
Priority setting for productivity indices in Iranian Pharmaceutical Companies Introduction M Annabi, A Kebriaeezadeh, SN Marashi-Shoshtari, S Ghodsi Journal of Pharmacoeconomics and Pharmaceutical Management 1 (1/2), 27-31, 2015 | 5 | 2015 |
Determining the entitlement to structural indicators of health by means of fuzzy AHP and TOPSIS: a case study in Sistan and Baluchestan, Iran H Hayati, S Karimi, J Sadeghifar, J Ebrahimzadeh, S Afshari, B Khosravi, ... Journal of Pharmacoeconomics and Pharmaceutical Management 1 (3/4), 61-64, 2015 | 4 | 2015 |
An evaluation of policies and procedures of successful pharmaceutical exporters and the comparison of Iranian counterpart policy M Seyedifar, S Nikfar, A Abdollahi-Asl, HR Rasekh, A Ehsani, ... Journal of Pharmacoeconomics and Pharmaceutical Management 1 (3/4), 39-44, 2015 | 4 | 2015 |
Quality assurance status in iranian pharmaceutical industry: A survey A Hosseinzadeh, A Yektadoost, H Hozouri, R Dinarvand, ... Journal of Pharmacoeconomics and Pharmaceutical Management 1 (1/2), 14-21, 2015 | 4 | 2015 |
Dietary supplements market size analysis in Iran from 2011 to 2015 AG Khosroshahi, P Saiyarsarai, A Yektadoost, A Jamshidi, AA Asl, ... Journal of Pharmacoeconomics and Pharmaceutical Management 3 (3/4), 41-47, 2017 | 3 | 2017 |
On the consideration of well-being and quality of life in hemodialysis patients I Zareban, M Seraji, D Shojaeezadeh, F Rakhshani Journal of Pharmacoeconomics and Pharmaceutical Management 3 (1/2), 12-16, 2017 | 3 | 2017 |
The quality of life in hemodialysis patients referring to hospitals of Zahedan University of Medical Sciences M Seraji, D Shojaeezadeh, R Sadeghi Journal of Pharmacoeconomics and Pharmaceutical Management 3 (1/2), 1-4, 2017 | 3 | 2017 |
Identification of the business model components of the Iranian pharmaceutical companies M Ebrahimi, MT Taqhavi-Fard, MR Karimi-Alavijeh, AA Halvaei Journal of Pharmacoeconomics and Pharmaceutical Management 2 (3/4), 64-70, 2016 | 3 | 2016 |
Parental self-medication with antibiotics in Iran F Zeinali, N Yousefi, F Peiravian Journal of Pharmacoeconomics and Pharmaceutical Management 2 (3/4), 60-63, 2016 | 3 | 2016 |
The knowledge of pharmacists about cosmetics in pharmacies of Tehran, Iran G Ghiasi, F Hashemian, A Kebriaeezadeh, S Ghiasi Journal of Pharmacoeconomics and Pharmaceutical Management 2 (1/2), 34-37, 2016 | 3 | 2016 |
The relationship between socioeconomic and therapeutic factors with the quality of life among the patients type II diabetes M Toroski, R Rajabzadeh, M Niyazi, H Hayati, HS Shakeri, M Rezapour, ... Journal of Pharmacoeconomics and Pharmaceutical Management 2 (1/2), 19-24, 2016 | 2 | 2016 |
Assessing the Medicines Use in the Elderly: A New Approach to Promote Rational Medicine Use in this Group F Soleymani, N Ashrafi, A Tehrani-banihashemi, N Mohammad-Hosseini, ... Journal of Pharmacoeconomics and Pharmaceutical Management 1 (1/2), 10-13, 2015 | 2 | 2015 |
Cost-utility analysis of interferon beta-1a (Avonex and Cinnovex) for relapsing remitting multiple sclerosis RS Shahtaheri, N Hatam, Z Goudarzi Journal of Pharmacoeconomics and Pharmaceutical Management 2 (3/4), 50-54, 2016 | 1 | 2016 |
Evaluation of equity in access to pharmaceutical services in selected cites of Isfahan Province, Iran M Davari, MR Maracy, A Aslani, Z Bakhshizadeh, E Khorasani Journal of Pharmacoeconomics and Pharmaceutical Management 2 (1/2), 25-29, 2016 | 1 | 2016 |